christine winoto, director
Christine Winoto is Director of the Rosenman Institute, Deputy Director of QB3, and Founding Partner at MedTech Venture Partners I, LLP. Christine manages the Rosenman Institute, Biotech/Biopharma Pitch Summits, corporate partnership, and QB3 operations. She is also host of the Health Technology podcast. Before joining QB3, she managed business strategy and capital planning for Kaiser Permanente both on the hospital and health plan sides, and managed business development at Genencor. In addition to consulting for startups and venture capital, she has also held R&D and operations positions in medical device companies including Physiometrix (IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine also worked in mergers and acquisitions at the London office of the Dutch investment bank ABN AMRO. Christine holds an MBA from Erasmus University in the Netherlands.
Ioana Aanei, entrepreneurship programs
Ioana earned her B.S. in Chemistry from the California Institute of Technology and a PhD degree in Chemical Biology from UC Berkeley. Through her position as Entrepreneurship Program Manager at QB3, Ioana is helping scientists launch companies in the life sciences field through the QB3 Startup in a Box program. Ioana directs several workshops, seminars, partnering days and office hours aimed at supporting early stage companies with grant writing, IP protection and operations. She is also leading two QB3 initiatives around Aging and Fibrosis, respectively.
Karen Boezi, executive mentorship
Karen is a member of Broadway Angels and is launching QB3 and the Rosenman Institute's Executive Mentorship program. Previously, Karen was the CEO of Redwood Bioscience which she joined as the first non-founder employee, leading the company through its successful acquisition by Catalent (CTLT). Redwood, now Catalent Biologics, continues to be a pioneer in developing therapeutic conjugate technology and antibody-drug conjugates for improving cancer treatment. Prior to joining Redwood, Karen co-founded and was a Partner with Thomas, McNerney & Partners, a health care technology-focused venture firm with $600 million under management. Previously, she was a General Partner of Coral Ventures and a member of Warburg Pincus LLC’s healthcare technology venture group. During her venture career, Karen was involved with 15 companies from initial investment that went public and/or were acquired; three of which she launched in collaboration with scientific founders. Karen began her career as a member of Alex. Brown & Sons’s health care and insurance corporate finance teams. She graduated Phi Beta Kappa and magna cum laude with a B.S. in Economics from the Wharton School at the University of Pennsylvania.
Kaspar Mossman, communications & marketing
Kaspar Mossman engages internal and external stakeholders in QB3’s mission to support research and commercialization in quantitative biosciences. He manages the QB3 website, newsletter, email, event marketing, multimedia, social media, and print publications. Previously, he worked on the media staff at Proceedings of the National Academy of Sciences and held an AAAS mass media fellowship at Scientific American. He earned a Ph.D. in biophysics from UC Berkeley.
Herminio Neto, events, Programs, & logistics
Herminio Neto, an administrative professional with expertise in project management, logistics, organization, and customer service, manages the implementation of large-scale University of California events affiliated with QB3 programs. Prior to QB3, Herminio worked as a business analyst in the HR department at UCSF, where he provided business operational and administrative services to more than 185 employees. Herminio is a dual citizen of the United States and Brazil.